AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate
AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs. The post AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate appeared first on Investor's Business Daily.
AbbVie stock surged early Friday after beating fourth-quarter expectations, largely on the back of its immunology drugs.
The post AbbVie Jumps After Its Powerhouses, Skyrizi And Rinvoq, Continued To Dominate appeared first on Investor's Business Daily.
iShook Opinion
"iShook Opinion" by Beni E Rachmanov, CEO & Founder of iShook. Explore captivating perspectives on entertainment, lifestyle, and sports at ishookdaily.com. Your go-to for engaging insights.
